Cargando…
Relationships of serum CC16 levels with smoking status and lung function in COPD
BACKGROUND: The club cell secretory protein (CC16) has anti-inflammatory and antioxidant effects, and low CC16 serum levels have been associated with both risk and progression of COPD, yet the interaction between smoking and CC16 on lung function outcomes remains unknown. METHODS: Utilizing cross-se...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479424/ https://www.ncbi.nlm.nih.gov/pubmed/36114505 http://dx.doi.org/10.1186/s12931-022-02158-8 |
_version_ | 1784790787902406656 |
---|---|
author | Gribben, Kelli C. Poole, Jill A. Nelson, Amy J. Farazi, Paraskevi A. Wichman, Christopher S. Heires, Art J. Romberger, Debra J. LeVan, Tricia D. |
author_facet | Gribben, Kelli C. Poole, Jill A. Nelson, Amy J. Farazi, Paraskevi A. Wichman, Christopher S. Heires, Art J. Romberger, Debra J. LeVan, Tricia D. |
author_sort | Gribben, Kelli C. |
collection | PubMed |
description | BACKGROUND: The club cell secretory protein (CC16) has anti-inflammatory and antioxidant effects, and low CC16 serum levels have been associated with both risk and progression of COPD, yet the interaction between smoking and CC16 on lung function outcomes remains unknown. METHODS: Utilizing cross-sectional data on United States veterans, CC16 serum concentrations were measured by ELISA and log transformed for analyses. Spirometry was conducted and COPD status was defined by post-bronchodilator FEV(1)/FVC ratio < 0.7. Smoking measures were self-reported on questionnaire. Multivariable logistic and linear regression were employed to examine associations between CC16 levels and COPD, and lung function with adjustment for covariates. Unadjusted Pearson correlations described relationships between CC16 level and lung function measures, pack-years smoked, and years since smoking cessation. RESULTS: The study population (N = 351) was mostly male, white, with an average age over 60 years. An interaction between CC16 and smoking status on FEV(1)/FVC ratio was demonstrated among subjects with COPD (N = 245, p = 0.01). There was a positive correlation among former smokers and negative correlation among current or never smokers with COPD. Among former smokers with COPD, CC16 levels were also positively correlated with years since smoking cessation, and inversely related with pack-years smoked. Increasing CC16 levels were associated with lower odds of COPD (OR(adj) = 0.36, 95% CI 0.22–0.57, P(adj) < 0.0001). CONCLUSIONS: Smoking status is an important effect modifier of CC16 relationships with lung function. Increasing serum CC16 corresponded to increases in FEV(1)/FVC ratio in former smokers with COPD versus opposite relationships in current or never smokers. Additional longitudinal studies may be warranted to assess relationship of CC16 with smoking cessation on lung function among subjects with COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02158-8. |
format | Online Article Text |
id | pubmed-9479424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94794242022-09-17 Relationships of serum CC16 levels with smoking status and lung function in COPD Gribben, Kelli C. Poole, Jill A. Nelson, Amy J. Farazi, Paraskevi A. Wichman, Christopher S. Heires, Art J. Romberger, Debra J. LeVan, Tricia D. Respir Res Research BACKGROUND: The club cell secretory protein (CC16) has anti-inflammatory and antioxidant effects, and low CC16 serum levels have been associated with both risk and progression of COPD, yet the interaction between smoking and CC16 on lung function outcomes remains unknown. METHODS: Utilizing cross-sectional data on United States veterans, CC16 serum concentrations were measured by ELISA and log transformed for analyses. Spirometry was conducted and COPD status was defined by post-bronchodilator FEV(1)/FVC ratio < 0.7. Smoking measures were self-reported on questionnaire. Multivariable logistic and linear regression were employed to examine associations between CC16 levels and COPD, and lung function with adjustment for covariates. Unadjusted Pearson correlations described relationships between CC16 level and lung function measures, pack-years smoked, and years since smoking cessation. RESULTS: The study population (N = 351) was mostly male, white, with an average age over 60 years. An interaction between CC16 and smoking status on FEV(1)/FVC ratio was demonstrated among subjects with COPD (N = 245, p = 0.01). There was a positive correlation among former smokers and negative correlation among current or never smokers with COPD. Among former smokers with COPD, CC16 levels were also positively correlated with years since smoking cessation, and inversely related with pack-years smoked. Increasing CC16 levels were associated with lower odds of COPD (OR(adj) = 0.36, 95% CI 0.22–0.57, P(adj) < 0.0001). CONCLUSIONS: Smoking status is an important effect modifier of CC16 relationships with lung function. Increasing serum CC16 corresponded to increases in FEV(1)/FVC ratio in former smokers with COPD versus opposite relationships in current or never smokers. Additional longitudinal studies may be warranted to assess relationship of CC16 with smoking cessation on lung function among subjects with COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-022-02158-8. BioMed Central 2022-09-16 2022 /pmc/articles/PMC9479424/ /pubmed/36114505 http://dx.doi.org/10.1186/s12931-022-02158-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Gribben, Kelli C. Poole, Jill A. Nelson, Amy J. Farazi, Paraskevi A. Wichman, Christopher S. Heires, Art J. Romberger, Debra J. LeVan, Tricia D. Relationships of serum CC16 levels with smoking status and lung function in COPD |
title | Relationships of serum CC16 levels with smoking status and lung function in COPD |
title_full | Relationships of serum CC16 levels with smoking status and lung function in COPD |
title_fullStr | Relationships of serum CC16 levels with smoking status and lung function in COPD |
title_full_unstemmed | Relationships of serum CC16 levels with smoking status and lung function in COPD |
title_short | Relationships of serum CC16 levels with smoking status and lung function in COPD |
title_sort | relationships of serum cc16 levels with smoking status and lung function in copd |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479424/ https://www.ncbi.nlm.nih.gov/pubmed/36114505 http://dx.doi.org/10.1186/s12931-022-02158-8 |
work_keys_str_mv | AT gribbenkellic relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT poolejilla relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT nelsonamyj relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT faraziparaskevia relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT wichmanchristophers relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT heiresartj relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT rombergerdebraj relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd AT levantriciad relationshipsofserumcc16levelswithsmokingstatusandlungfunctionincopd |